What is Foolsaurus?

It's a glossary of investing terms edited and maintained by our analysts, writers and YOU, our Foolish community. Get Started Now!


Cephalon

Cephalon (Nasdaq: CEPH) is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat human diseases. Currently its four core therapeutic areas are central nervous system disorders, pain, cancer and addiction.

Company Description

Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system (“CNS”), pain, oncology, and their latest area of focus, inflammatory diseases. In addition to conducting an active research and development program, they market seven proprietary products in the United States and numerous products in various countries throughout Europe and the world. Consistent with their core therapeutic areas, Cephalon has aligned their approximately 780-person U.S. field sales and sales management teams by area. They have a sales and marketing organization numbering approximately 400 persons that supports their presence in nearly 20 European countries, including France, the United Kingdom, Germany, Italy and Spain, and certain countries in Africa and the Middle East.

Source: Cephalon May 6th, 2009 10-Q

Related Companies

Recent Mentions on Fool.com

Advertisement